Skip to main content
$18.48 $0.33 (1.8%)

04:00 PM EST on 01/24/22

Editas Medicine (NASDAQ:EDIT)

CAPS Rating: 5 out of 5

Current Price $18.48 Mkt Cap $1.3B
Open $17.57 P/E Ratio 0.00
Prev. Close $18.48 Div. (Yield) $0.00 (0.0%)
Daily Range $16.37 - $18.63 Volume 280
52-Wk Range $16.37 - $73.03 Avg. Daily Vol. 1,747,889

Caps

How do you think NASDAQ:EDIT will perform against the market?

Add Stock to CAPS Watchlist

All Players

345 Outperform
7 Underperform
 

All-Star Players

85 Outperform
1 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

Top NASDAQ:EDIT Bull/Bear Pitches

The best Bull and Bear pitches based on recency and number of recommendations.

Ficktory (20.82)
Submitted December 17, 2021

Gene editing will be a huge growth industry in the future of health care

LastPlaceLenny (46.34)
Submitted March 15, 2019

Not ready to take off yet, will out perform in long run, but not sure when that long run starts. Not this year.

NASDAQ:EDIT VS S&P 500 (SPY)

NASDAQ:EDIT Summary

Fools bullish on NASDAQ:EDIT are also bullish on:

Fools bearish on NASDAQ:EDIT are also bearish on:

Recent Community Commentary

Read the most recent pitches from players about EDIT.

Recs

1
Member Avatar Ficktory (20.82) Submitted: 12/17/2021 9:26:04 AM : Outperform Start Price: $27.67 NASDAQ:EDIT Score: -28.77

Gene editing will be a huge growth industry in the future of health care

Recs

0
Member Avatar Deusa (< 20) Submitted: 10/13/2021 12:03:40 PM : Outperform Start Price: $37.94 NASDAQ:EDIT Score: -52.70

The right product
No reason as far as I can make out for the sell off
Oversold on a falling market
from my research fair value $60+

Recs

0
Member Avatar marty500 (< 20) Submitted: 9/3/2021 9:34:57 AM : Outperform Start Price: $71.02 NASDAQ:EDIT Score: -71.25

Crisper is long term factor. Plenty of new applications will follow

Leaderboard

Find the members with the highest scoring picks in EDIT.

Score Leader

Dobby62

Dobby62 (50.45) Score: +242.71

The Score Leader is the player with the highest score across all their picks in EDIT.

Top
Pick
Member Name Member
Rating
Start
Date
Call Time
Frame
Start
Price
Stock
Gain
Index
Gain
Score Commentary
SeriousK 28.79 3/9/2016 Underperform 5Y $42.70 -56.72% +120.57% +177.29 0 Comment
TimeToBuy 91.02 3/10/2016 Underperform 5Y $32.50 -43.14% +119.90% +163.04 0 Comment
nobody2013 < 20 3/10/2016 Underperform NS $26.79 -31.02% +121.78% +152.80 1 Comment
btechrisk11 < 20 4/16/2018 Underperform 3Y $34.93 -47.09% +64.69% +111.78 1 Comment
chushogi 64.36 1/9/2017 Underperform 5Y $18.05 +2.38% +93.79% +91.40 0 Comment
LastPlaceLenny 46.34 3/15/2019 Underperform 1Y $24.03 -23.10% +56.74% +79.84 1 Comment
hayrettin 72.35 1/18/2022 Underperform 5Y $20.59 -10.23% -3.97% +6.25 0 Comment
foolarooskie 51.78 1/14/2022 Outperform 5Y $21.49 -14.01% -4.66% -9.35 0 Comment
MexicanFool99 68.45 1/7/2022 Outperform 5Y $24.41 -24.29% -6.03% -18.26 0 Comment
Ficktory 20.82 12/17/2021 Outperform 5Y $27.67 -33.20% -4.43% -28.77 1 Comment

Wall Street

See what the Wall Street professionals think, according to their public statements and filings.

There are no Wall Street tracker picks for EDIT.